TRACEY DINAC: Open Payments
NPI 1134676661 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 19 payments from 10 companies in 2025. Trend: 2023 $397 · 2024 $99 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| ViiV Healthcare Company | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $89 |
| Biogen, Inc. | 3 | $84 |
| SHIELD THERAPEUTICS INC | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| MILLICENT US INC | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $17 |
Products named: Wegovy, APRETUDE, LEQVIO, ZURZUVAE, ACCRUFER, MYFEMBREE, JOURNAVX, INTRAROSA.
Industry payments across NY — which companies pay providers there.
